Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study

In the Original Publication of the article, In Introduction part, 7th line, the value “5-100nM” has been published incorrectly. The correct value should read as “Plasma concentration of 50-100ng/ml”. In the Original Publication of the article, page 591, Table 2 has been published incorrectly. The corrected table is shown in the following page
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research